These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11081376)

  • 1. [Hormone replacement: side effects and problems].
    Kueng F
    Ther Umsch; 2000 Oct; 57(10):643-5. PubMed ID: 11081376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone replacement therapy in peri- and postmenopause].
    Henes M; Hübner S
    Internist (Berl); 2020 Jun; 61(6):558-564. PubMed ID: 32333087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modern approach to postmenopausal HRT: trading bleeding with safety.
    Al-Azzawi F; Wahab M
    Womens Health (Lond); 2012 Jan; 8(1):1-4. PubMed ID: 22171766
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased coronary events, HERS, and HRT: any connection?
    Rebar RW; Archer D
    Arch Intern Med; 2001 May; 161(10):1350-1. PubMed ID: 11371266
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension.
    Sriprasert I; Beydoun H; Barnabei V; Nassir R; LaCroix AZ; Archer DF
    Menopause; 2015 Oct; 22(10):1067-75. PubMed ID: 25756697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
    Douketis JD; Julian JA; Kearon C; Anderson DR; Crowther MA; Bates SM; Barone M; Piovella F; Turpie AG; Middeldorp S; van Nguyen P; Prandoni P; Wells PS; Kovacs MJ; MacGillavry MR; Costantini L; Ginsberg JS
    J Thromb Haemost; 2005 May; 3(5):943-8. PubMed ID: 15869589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
    Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
    [No Abstract]   [Full Text] [Related]  

  • 13. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and venous thromboembolism.
    Peverill RE
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):149-64. PubMed ID: 12763518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in postmenopausal women with heart disease and risk for gallstones that require surgery.
    Ann Intern Med; 2001 Oct; 135(7):S-44. PubMed ID: 11596574
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical review of the article by Colditz et al. on 'The use of estrogens and progestins and the risk of breast cancer in postmenopausal women' published in the N.E.J.M. 1995, 332: 1589.
    Sismondi P; Biglia N
    Pharmacol Res; 1995 Dec; 32(6):329-30. PubMed ID: 8736482
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.